Technology Alpha Tau Announces Alpha DaRT Treatment of First Two Patients in its Pivotal Multicenter Recurrent… GlobeNewswire Mar 9, 2023 -First two US patients with recurrent cutaneous squamous cell carcinoma have been treated at University Cancer Center in Houston, Texas -Up to 86…
Machine Learning Yasheng’s AI-Powered Cancer Therapy Patent Revolutionizes Immunotherapy Development PRNewswire Feb 28, 2023 Yasheng Group,an agricultural and biotech company with U.S. headquarters in San Jose, California announced that HERB filed for patent protection with…
Healthcare Management OncoHost Announces Interim Results From PROPHETIC Trial, Multicenter Assessment Of NSCLC Patient… AIT News Desk Jan 17, 2022 With One Blood Test Pre-Treatment, PROphet® Provides Response Probability for the First Year of Treatment, Plus Analysis of Resistance Associated…